Missed Diagnosis of Gestational Diabetes Mellitus Due to Selective Screening: Evidence from a Cross-Sectional Study in the West Nile Sub-Region, Uganda
Vincent Abindu,Derick Hope,Mary Aleni,Monicah Andru,Richard Ayiasi,Victor Afayo,Caesar Oyet,Ritah Kiconco
DOI: https://doi.org/10.2147/dmso.s447855
2024-03-13
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Vincent Abindu, 1 Derick Hope, 2 Mary Aleni, 1 Monicah Andru, 1 Richard Mangwi Ayiasi, 3 Victor Afayo, 4 Caesar Oyet, 5 Ritah Kiconco 6, 7 1 Department of Nursing and Midwifery - Faculty of Health Sciences, Muni University, Arua, West Nile, Uganda; 2 Department of Medical Laboratory Science - Faculty of Health Sciences, Muni University, Arua, West Nile, Uganda; 3 Department of Public Health - Faculty of Health Sciences, Muni University, Arua, West Nile, Uganda; 4 Department of Obstetrics and Gynaecology, Arua Regional Referral Hospital, Arua, West Nile, Uganda; 5 Department of Medical Laboratory Science - Faculty of Health Sciences, Clark International University, Kampala, Central, Uganda; 6 Department of Clinical Biochemistry - Faculty of Health Sciences, Soroti University, Soroti, Teso, Uganda; 7 Department of Medical Laboratory Sciences - Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Southwestern, Uganda Correspondence: Derick Hope, Department of Medical Laboratory Science - Faculty of Health Sciences, Muni University, Arua, West Nile, Uganda, Tel +256 772832320, Fax +256 476 420316, Email Purpose: To ascertain the prevalence and risk factors of gestational diabetes mellitus (GDM) in pregnant women receiving antenatal care (ANC) services within the West Nile subregion of Uganda. Patients and Methods: An analytical cross-sectional study was conducted on 233 pregnant women who are within 24– 28 weeks of gestation and are receiving ANC services in selected hospitals. GDM was diagnosed according to the World Health Organization (WHO) criteria (2013). A questionnaire and anthropometric measurements were used to obtain relevant data. The chi-square test and logistic regression were used to determine the association between GDM and the study variables, including participants' sociodemographic and medical characteristics. Results: The prevalence of hyperglycemia first detected in pregnancy among the participants tested was 8%. Overall, 7.45% had GDM and 0.53% had diabetes mellitus in pregnancy. The fasting plasma glucose test alone was positive in 86.7% of the GDM cases. The factors that were significantly associated with GDM included age ≥ 25 years (p = 0.017, AOR = 3.51) and body mass index (BMI) ≥ 25 kg/m 2 (p = 0.024, AOR = 2.67). Out of the participants diagnosed with GDM, 28.6% did not have a known risk factor. Of the pregnant women with GDM, 57% would have been missed if the selective screening in the national clinical guidelines had been followed. Urinary tract infection (UTI) and Candida were detected in 36.36% and 13.85% of the participants, respectively. Conclusion: The study provides new data on the prevalence of GDM in rural settings in the West Nile subregion of Uganda. Of the participants, 7.5% were diagnosed with GDM, of which 57% would have been missed based on the selective screening of the national clinical guidelines. The study findings support the universal screening of GDM in pregnant women. Keywords: prevalence, gestational diabetes mellitus, risk factors, selective screening Gestational diabetes mellitus (GDM) is a type of diabetes with onset or first recognition during pregnancy, where blood glucose levels are higher than normal values (hyperglycemia) but below those diagnostic of overt diabetes. 1,2 GDM occurs when less insulin is produced than the body's needs or when the body cannot adequately use the insulin it produces due to hormonal and metabolic changes during pregnancy. 3,4 GDM usually has no symptoms but nonspecific and mild manifestations, including increased frequency or urgency of micturition, increased thirst, fatigue, weight loss, and blurred vision, some of which are consistent with symptoms in normal pregnancy; hence, the recommended diagnosis is through screening rather than clinically. 5 If not managed well, GDM can result in serious consequences for the affected pregnant woman and/or the unborn baby or complications later in life for the two. Complications in the pregnant woman include preeclampsia, hypertension, cesarean section, type 2 diabetes later in life, GDM in subsequent pregnancies, induced labor, and antepartum hemorrhage. 6–8 Complications in the affected baby include macrosomia, large-for-gestational-age, preterm birth, stillbirth, hypoglycemia, serious breathing problems such as respiratory distress syndrome, shoulder dystocia, neonatal jaundice, obesity or type 2 diabetes later in life, cardiac diseases, and intensive care unit admissions for neonates with outcomes of prenatal mortality. 8–10 The incidence of GDM -Abstract Truncated-
endocrinology & metabolism